347
Participants
Start Date
August 31, 2002
Primary Completion Date
August 31, 2003
Study Completion Date
August 31, 2003
insulin detemir
insulin NPH
insulin aspart
Novo Nordisk Investigational Site, Skopje
Novo Nordisk Investigational Site, Ljubljana
Novo Nordisk Investigational Site, Sarpsborg
Novo Nordisk Investigational Site, Glostrup Municipality
Novo Nordisk Investigational Site, Edegem
Novo Nordisk Investigational Site, Tønsberg
Novo Nordisk Investigational Site, Bree
Novo Nordisk Investigational Site, Odense
Novo Nordisk Investigational Site, Kolding
Novo Nordisk Investigational Site, Zurich
Novo Nordisk Investigational Site, Bodø
Novo Nordisk Investigational Site, Caen
Novo Nordisk Investigational Site, Kiel
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Leganés
Novo Nordisk Investigational Site, Hanover
Novo Nordisk Investigational Site, Toulouse
Novo Nordisk Investigational Site, Rennes
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Frankfurt
Novo Nordisk Investigational Site, Stuttgart
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Rijeka
Novo Nordisk Investigational Site, Viborg
Novo Nordisk Investigational Site, Dublin
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Eindhoven
Novo Nordisk Investigational Site, Spijkenisse
Novo Nordisk Investigational Site, Utrecht
Novo Nordisk Investigational Site, Gjøvik
Novo Nordisk Investigational Site, Helsingborg
Novo Nordisk Investigational Site, Linköping
Novo Nordisk Investigational Site, Lund
Novo Nordisk Investigational Site, Malmo
Novo Nordisk Investigational Site, Örebro
Novo Nordisk Investigational Site, Stockholm
Novo Nordisk Investigational Site, Aberdeen
Novo Nordisk Investigational Site, Belfast
Novo Nordisk Investigational Site, Birmingham
Novo Nordisk Investigational Site, Glasgow
Novo Nordisk Investigational Site, Stirling
Lead Sponsor
Novo Nordisk A/S
INDUSTRY